Interv Akut Kardiol. 2003;2(2):69-72

NEW INSIGHTS INTO THE PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROME

Jan Vojáček1,2, Martin Mates2, Vladimír Hraboš3
1 I. interní klinika Fakultní nemocnice v Hradci Králové
2 Kardiocentrum dospělých, oddělení invazivní kardiologie interní kliniky 2. LF UK a FN Motol, Praha
3 Kardiologické oddělení, Krajská nemocnice Liberec

Coronary lesions in patients with acute coronary syndrome are usually multifocal. Intracoronary ultrasound examination of all three coronary arteries in patients with troponine-pozitive acute coronary syndrome demonstrated in almost 80 % of patients more than one culprit lesion located in any part of coronary vascular bed.

Circulating monocytes and platelets and their interactions are responsible for the development of coronary thrombosis. Activated monocytes express tissue factor, some cytokines and matrix metalloproteinases. The importance of CD40 receptor on monocytes, endothelial cells and smooth muscle cells and its interaction with CD40 ligand shed by platelets was recognized. Matrix metalloproteinases are found not only in the histological specimens of ruptured plaque but their levels are also increased in the plasma of patients with acute coronary syndrome.

Invasive treatment of patients with acute coronary syndrome proved to improve their prognosis. However, adjunctive treatment with potent antiplatelet drugs, such as platelet GP IIb/IIIa receptor inhibitor and ADP pathway blockers also improve long-term survival of patients with acute coronary syndromes.

Keywords: acute coronary syndrome, platelets, monocytes, multifocal coronary involvement.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vojáček J, Mates M, Hraboš V. NEW INSIGHTS INTO THE PATHOPHYSIOLOGY OF ACUTE CORONARY SYNDROME. Interv Akut Kardiol. 2003;2(2):69-72.
Download citation

References

  1. Ambrose JA, et al. Angiographic evaluation of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986; 7: 472-478. Go to original source... Go to PubMed...
  2. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Management of acute coronary syndromes in patients presenting without persistent ST segment elevation. Eur Heart J 2002; 23: 1809-1840. Go to original source... Go to PubMed...
  3. Stefanadis C, Toutouzas K, Tsiamis E, et al. Increased local temperature in human scoronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention. J Am Coll Cardiol 2001; 37: 1277-1283. Go to original source... Go to PubMed...
  4. Komiyama N, Berry GJ, Kolz ML, et al. Tissue characterization of atherosclerotic plaques by intravascular ultrasound radiofrequency signal analysis: An in vitro study of human coronary arteries. Am Heart J 2000; 140: 565-574. Go to original source... Go to PubMed...
  5. Asakura M, Ueda Y, Yamaguchi O, et al. Extensive development of vulnerable plaques as a pan-coronary process in patients with myocardial infarction: an angioscopic study. J Am Coll Cardiol 2001; 37: 1284-1288. Go to original source... Go to PubMed...
  6. Casscells W, Hathorn B, David M et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implication of plaque rupture and thrombosis. Lancet 1996; 347: 1447-1451. Go to original source... Go to PubMed...
  7. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L for TRIM Study Group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997; 96: 2578-2585. Go to original source... Go to PubMed...
  8. Morrow DA, Rifai A, Antman E, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol, 1998; 31: 1460-1465. Go to original source... Go to PubMed...
  9. Kennon S, Price CP, Mills PG et al. The effect of aspirin on C-reactive protein as a marker of risk in unstable angina. J Am Coll Cardiol 2001; 37: 1266-1270. Go to original source... Go to PubMed...
  10. Nissen SE, Yock P. Intravascular ultrasound. Novel pathophysiological insights and current clinical applications. Circulation 2001; 103: 604-616. Go to original source... Go to PubMed...
  11. Spagnoli LG, Bonanno E, Mauriello A et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002; 40: 1579-1588. Go to original source... Go to PubMed...
  12. Buffon A, Biasucci LM, Liuzzo G, D´Onofrio G, Crea F, Maseri A. Widespread coronary infammation in unstable angina. N Engl J Med 2002; 347: 5-12. Go to original source... Go to PubMed...
  13. Goldstein JA, Demetriou D, Grines C et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343: 915-922. Go to original source... Go to PubMed...
  14. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome. A three - vessel intravascular ultrasound study. Circulation 2002; 106: 804-808. Go to original source... Go to PubMed...
  15. Smits PC, Pasterkamp G, de Jaegere PP, et al. Angioscopic complex lesions are predominantly compensatory enlarged: an angioscopic and intracoronary ultrasound study. Cardiovasc Res 1999; 41: 458-464. Go to original source... Go to PubMed...
  16. Nakamura M, Nishikawa H, Mukai S et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol 2001; 37: 63-69. Go to original source... Go to PubMed...
  17. Toschi V, Gallo R, Lettino M et al. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997; 95: 594-599. Go to original source... Go to PubMed...
  18. Vojáček J, Malý M, Hraboš V, et al. Hladina tkáňového faktoru, inhibitoru tkáňového faktoru a solubilního P-selektinu u nemocných s akutním koronárním syndromem. Cor Vasa 2002; 44: 148-151.
  19. Vojáček J, Malý M, Hraboš V et al. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with acute coronary syndrome. Abstract Eur Heart J 2002; 23 Suppl 8/9: 21.
  20. Zalai CV, Kolodziejczyk MD, Pilarski L et al. Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 2001; 38: 1340-1347. Go to original source... Go to PubMed...
  21. Furman MI, Barnard MR, Krueger LA, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-1006. Go to original source... Go to PubMed...
  22. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-594. Go to original source... Go to PubMed...
  23. Schonbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89: 1092-1103. Go to original source... Go to PubMed...
  24. Bayes-Gedus A, Conover CA, Overgaard MT, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022-1029. Go to original source... Go to PubMed...
  25. Hájek P, Macek M, Vojáček J, et al. Pregnancy-associated plasma protein a (PAPP-a) in determination of unstable coronary plaque. Abstract Eur Heart J 2002; 23 Suppl 8/9: 293.
  26. Fragmin and Fast Revascularization during InStability in Coronary artery disease (FRISC II) investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999; 354: 708-715.
  27. Nunn CM, O´Neill WW, Rothbaum D, Stone GW, O´Keefe J, Overlie P et al. Long-term outcome after primary angioplasty: Report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) Trial. J Am Coll Cardiol 1999; 33: 640-646. Go to original source... Go to PubMed...
  28. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494-502. Go to original source... Go to PubMed...
  29. Mehta SR, Yusuf S, Peters RJG, et al for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527/33. Go to original source... Go to PubMed...
  30. Topol EJ, Lincoff AM, Kereiakes DJ, et al. Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization. Am J Med 2002; 113: 1-6. Go to original source... Go to PubMed...
  31. Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol 2000; 35: 922-928. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.